BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33471267)

  • 1. Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.
    Tabchouri N; Buggisch J; Demtröder CR; Thiery J; Rezniczek G; Tempfer CB; Fischer B; Dogan C; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2021 Sep; 28(9):5275-5286. PubMed ID: 33471267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
    Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
    Taibi A; Sgarbura O; Hübner M; Bardet SM; Alyami M; Bakrin N; Durand Fontanier S; Eveno C; Gagniere J; Pache B; Pocard M; Quenet F; Teixeira Farinha H; Thibaudeau E; Dumont F; Glehen O
    Ann Surg Oncol; 2022 Aug; 29(8):5243-5251. PubMed ID: 35318519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
    Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
    Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
    Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
    Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.
    Lurvink RJ; Rovers KP; Nienhuijs SW; Creemers GJ; Burger JWA; de Hingh IHJ
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S242-S258. PubMed ID: 33968441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).
    Lurvink RJ; Rovers KP; Wassenaar ECE; Bakkers C; Burger JWA; Creemers GM; Los M; Mols F; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    Surg Endosc; 2022 Jun; 36(6):4486-4498. PubMed ID: 34757489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
    Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
    Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.
    Graversen M; Detlefsen S; Pfeiffer P; Lundell L; Mortensen MB
    Clin Exp Metastasis; 2018 Mar; 35(3):103-108. PubMed ID: 29705882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
    Sgarbura O; Hübner M; Alyami M; Eveno C; Gagnière J; Pache B; Pocard M; Bakrin N; Quénet F
    Eur J Surg Oncol; 2019 Dec; 45(12):2386-2391. PubMed ID: 31092362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
    Ramos Arias G; Sindayigaya R; Ouaissi M; Buggisch JR; Schmeding M; Giger-Pabst U; Zieren J
    Ann Surg Oncol; 2023 Apr; 30(4):2497-2505. PubMed ID: 36400887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
    Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
    van de Vlasakker VCJ; Lurvink RJ; Wassenaar EC; Rauwerdink P; Bakkers C; Rovers KP; Bonhof CS; Burger JWA; Wiezer MJ; Boerma D; Nienhuijs SW; Mols F; de Hingh IHJT
    Sci Rep; 2023 Nov; 13(1):20458. PubMed ID: 37993560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
    Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
    Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
    J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
    Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
    BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.